Rapporto sull’analisi delle dimensioni del mercato e delle quote del mercato degli inalatori medici | Previsioni 2031

  • Report Code : TIPRE00018804
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

INTRODUZIONE AL MERCATO Gli inalatori medici sono dispositivi medici utilizzati per somministrare vari farmaci tramite inalazione. I farmaci utilizzati negli inalatori includono anticolinergici, glucocorticoidi, insulina e beta-agonisti per il trattamento e la prevenzione di malattie respiratorie come l'asma e le malattie polmonari croniche ostruttive. Gli inalatori intelligenti sono un tipo di inalatori medici dotati di sensori fissati come una clip sugli inalatori che monitorano la giusta dose per assunzione e la tecnica utilizzata per l'inalazione del farmaco. I dati ottenuti dal sensore vengono condivisi con il paziente e gli operatori sanitari per monitorare l'utilizzo dell'inalatore. Altri diversi tipi di inalatori includono l'inalatore a polvere secca, l'inalatore a dose preimpostata e altri. DINAMICHE DEL MERCATO Il mercato degli inalatori medici ha mostrato un'evoluzione significativa nel periodo di previsione. L’ascesa del mercato degli inalatori medici è guidata dalla maggiore prevalenza di persone che soffrono di asma e malattie polmonari croniche ostruttive e dai progressi tecnologici nello sviluppo di dispositivi e sistemi inalatori migliori e intelligenti. Inoltre, le iniziative governative volte al miglioramento delle infrastrutture sanitarie standard e una maggiore attenzione alla spesa sanitaria stanno aiutando questi paesi a concentrarsi sull’offerta di assistenza sanitaria di alta qualità. Sono stati compiuti sforzi approfonditi per controllare disturbi come l’asma e la malattia polmonare ostruttiva cronica (BPCO), che colpiscono la maggior parte della popolazione. Secondo l'OMS, nel 2016 più di 300 milioni di persone nel mondo sono affette da asma e più di 200 milioni da BPCO. Tuttavia, si prevede che i costi più elevati associati allo sviluppo di inalatori medici per l'asma e la BPCO freneranno la diffusione. crescita del mercato degli inalatori medici. AMBITO DI MERCATO L'"Analisi del mercato degli inalatori medici fino al 2031" è uno studio specializzato e approfondito dei dispositivi medici del settore sanitario, incentrato sull'analisi delle tendenze del mercato globale. Questo rapporto delinea il mercato degli inalatori medici con una segmentazione dettagliata del mercato per prodotto, applicazione e utente finale. Si stima che il mercato degli inalatori medici assisterà a un forte aumento durante il periodo di previsione. Si concentra sulle statistiche vitali sullo stato di mercato dei principali attori nel mercato Inalatori medici e offre opportunità e tendenze chiave del mercato. SEGMENTAZIONE DEL MERCATO Il mercato è classificato in base al prodotto, all'applicazione e all'utente finale. In base al prodotto, il mercato è segmentato come inalatore a polvere secca, inalatore a dose dosata e altri. In base all'applicazione, la segmentazione del mercato è in asma, malattia polmonare ostruttiva cronica e altro. In base all’utente finale, la segmentazione del mercato è in ospedali, cliniche, centri di assistenza respiratoria e altri. Il rapporto presenta un quadro dettagliato del settore, costituito da informazioni sia quantitative che qualitative. Offre uno schizzo e previsioni del mercato degli inalatori medici basati su vari segmenti. Il rapporto comprende anche le dimensioni del mercato e le stime previsionali dall'anno 2021 al 2031 rispetto a cinque regioni principali, vale a dire; Nord America, Asia-Pacifico (APAC), Europa, Medio Oriente e Africa (MEA) e America meridionale e centrale (SCAM). Il mercato degli inalatori medici in ciascuna regione viene quindi suddiviso in sottosegmenti nei rispettivi paesi e segmenti. Comprende l’analisi e le previsioni di 18 paesi a livello globale e le recenti tendenze e opportunità prevalenti nella regione. Il rapporto analizza i fattori che influenzano il mercato degli inalatori medici sia dal lato della domanda che da quello dell’offerta. Inoltre, valuta le dinamiche di mercato riguardanti il mercato durante il periodo di previsione, vale a dire fattori trainanti, restrizioni, opportunità e tendenze future. Consiste anche in un’analisi PEST precisa per tutte e cinque le regioni, vale a dire Nord America, Asia Pacifico, Europa, Medio Oriente e Africa e America meridionale e centrale, dopo aver valutato i fattori politici, sociali, economici e tecnologici che influenzano il mercato Inalatori medici. in queste regioni. ATTORI DI MERCATO Il rapporto contiene sviluppi critici nel mercato degli inalatori medici come strategie di crescita inorganica e organica. Diverse aziende stanno puntando su strategie di crescita organica come il lancio di prodotti, l’approvazione di prodotti e altri, come brevetti ed eventi. Le strategie di crescita inorganica osservate erano collaborazioni, acquisizioni e partnership. Diverse attività di questo tipo hanno aperto la strada all'elaborazione del business e della base clienti degli attori del mercato. Si stima che gli operatori del mercato degli inalatori medici avranno opportunità di crescita redditizie nei prossimi anni con la maggiore domanda di inalatori medici nel mercato globale. Di seguito è riportato l'elenco di alcune aziende impegnate nel mercato degli inalatori medici. Il rapporto offre anche i profili dei principali attori nel mercato degli inalatori medici, insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del mercato con informazioni sui profili aziendali, informazioni finanziarie degli ultimi tre anni, componenti e servizi forniti, sviluppo critico negli ultimi cinque anni. - GlaxoSmithKline plc. - Koninklijke Philips NV - AstraZeneca - Cipla Inc. - Boehringer Ingelheim International GmbH - Beximco Pharmaceuticals Ltd - Merck & Co., Inc. - Teva Pharmaceutical Industries Ltd - Chiesi Farmaceutici SpA - Medisol Lifescience Pvt. Ltd La ricerca dedicata e il team analitico di Insight Partner sono composti da professionisti esperti con competenze statistiche avanzate e offrono diverse opzioni di personalizzazione nel rapporto corrente.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the Medical Inhaler Market in 2023?

North America dominated the Medical Inhaler Market in 2023

What is one of the main future trends of the Medical Inhaler Market ?

Increasingly Patient-Centric Designs is likely to remain the key trend during the forecast period.

Which region is expected to witness the fastest growth rate by 2031?

Asia Pacific region is likely to witness the fastest growth rate during the forecast period.

What are the driving factors impacting the Medical Inhaler Market ?

The Medical Inhaler Market drivers include the Increasing Prevalence of Respiratory Disorders, Technological Advancements in Inhaler Devices, Growing Awareness and Education over Respiratory Health

Who are the prominent players in Medical Inhaler Market ?

GlaxoSmithKline plc., Koninklijke Philips N.V., AstraZeneca, Cipla Inc., Boehringer Ingelheim International GmbH, Beximco Pharmaceuticals Ltd are some prominent players in the Medical Inhaler Market

What is the expected CAGR of the Medical Inhaler Market ?

The Medical Inhaler Market is estimated to witness a CAGR of 9.7% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. GlaxoSmithKline plc.
2. Koninklijke Philips N.V.
3. AstraZeneca
4. Cipla Inc.
5. Boehringer Ingelheim International GmbH
6. Beximco Pharmaceuticals Ltd
7. Merck & Co., Inc.
8. Teva Pharmaceutical Industries Ltd
9. Chiesi Farmaceutici SpA
10. Medisol Lifescience Pvt. Ltd

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.